TB Is Still Rife Fifty Years After The Study Which Found A Cure

Tuberculosis: story or medical failure?

In a week when the world of medicine is celebrating the 50th anniversary of the first randomised controlled trial, Chris Holme, journalist at the Herald newspaper in Glasgow, laments the irony that half a century on, the disease that this trial found the means to eradicate, is still rife.

The MRC trial, which was published in the BMJ on 30 October 1948, found Streptomycin to be an effective treatment of tuberculosis. In a stinging attack in this week's BMJ, the author writes that despite the results of this trial there has been a failure to implement treatment regimens, which has led to an international resurgence of the disease.

The author details the path of complacency that he believes has led to the epidemic we are now witnessing in the 1990s and asks: "why after an estimated one million controlled trials on every treatment under the sun, have we failed to apply the results of the initial ones on tuberculosis chemotherapy?"


Chris Holme, Herald, Glasgow, Scotland

(Contact through Jill Shepherd at BMJ press office Wednesday 28 - Friday 30 October)


Contact: Jill Shepherd
BMJ-British Medical Journal

Page: 1

Related biology news :

1. Still waters? Clear-cutting robs the deep-sea of ancient treasures
2. Salmon Syndrome M74: Cause Still A Mystery
3. Fetal Surgery For Spina Bifida Still Under Investigation At VUMC
4. Rapid Population Growth Is Still A Problem
5. Creatine Works, But Long-Term Effects Are Still Unknown
6. HIV Patients Often Experience Viral "Breakthrough," But May Still Remain Healthy, San Francisco Study Finds
7. Reduced Nutrients Still Cause Problems In The Neuse And Tar-Pamlico Rivers
8. Fifty years later, famous photo is in OSUs Pauling collection
9. Years of research, thought lead geologist to propose new supercontinent Columbia
10. Fossilized Emu Eggshells Give Clues To 65,000 Years Of Vegetation And Climate Changes In Australia
11. Earliest Modern Tree Lived 360-345 Million Years Ago

Post Your Comments:

(Date:8/12/2020)... ... 12, 2020 , ... Mosio recently announced its newly updated ... agencies of all sizes. With a focus on tracking symptoms and monitoring outbreaks ... care, Mosio helps public health departments automate communications and provide more personalized care ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval from the ... ProText™, making them the first Wharton’s jelly allografts to be assigned a Q code ... solutions are the first Wharton’s jelly allograft product to be recognized as a 361 ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... therapeutics product portfolio with a near term focus on Type 2 diabetes and ... commercialization experience across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 2020 , ... Bode Technology, a leading provider ... through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical testing ... provides a turnkey solution that includes a comprehensive collection and virus-management program for ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
(Date:7/1/2020)... Colo. (PRWEB) , ... June ... ... of expert tissue data insights, today announced that the launch of a ... results along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight ...
(Date:6/28/2020)... ... June 26, 2020 , ... ... solutions providers, today announced its strong opposition to the recently introduced bicameral ... a blanket ban on most federal use of nearly all biometric and related ...
Breaking Biology Technology:
Cached News: